Mar
09
2010
Acute Heart Failure – Drug Pipeline Analysis and Market Forecasts to 2016
By rgunnam
and has no comments yet.
GlobalData predicts the AHF therapeutics market to be valued at $2.3 billion in 2009. The market is estimated to grow up to $2.6 billion in 2016, with a CAGR of 2.1%. Growth in the AHF market is driven by the increasing number of patients and the launch of new promising drugs during the next few
Also on Acute Heart Failure – Drug Pipeline Analysis and Market Forecasts to 2016